MVAL - Medical & Value and Access Liaison
Amgen
About this role
A Medical, Value & Access Liaison at Amgen is part of Medical Affairs focused on improving outcomes and access for osteoporosis patients by coordinating between healthcare institutions and internal teams. The role connects external healthcare stakeholders with Amgen’s evidence-generation and strategic functions to optimize patient pathways and system efficiency.
Skills
Qualifications
About Amgen
amgen.comIndustries
Healthcare, Manufacturing, Technology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Recent company news
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers
2 days ago
Franklin Resources Inc. Lowers Position in Amgen Inc. $AMGN
4 hours ago
Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference
13 hours ago
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
3 days ago
About Amgen
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Amgen.
Salary
$73k – $99k
per year
More jobs at Amgen
Similar Jobs
Medical Science Liaison
Diversity Employment
Medical Scientific Liaison - CVRM
American Association of Physicists in Medicine
Medical Value Liaison - Northeast
Dyne Therapeutics
Value Access & Public Affairs Manager - Rare Diseases
Ipsen
Medical Science Liaison, Quebec
CSL Innovation
Medical Value Liaison - West / Southwest
Dyne Therapeutics